Comorbidities and multi-organ injuries in the treatment of COVID-19

The Lancet

Volumn 395, Issue 10228, 2020, Pages e52-

  Wang, Tianbing ^a   Du, Zhe ^a   Zhu, Fengxue ^a   Cao, Zhaolong ^a   An, Youzhong ^a   Gao, Yan ^a   Jiang, Baoguo ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIVIRUS AGENT; GLUCOCORTICOID;

ARTIFICIAL VENTILATION; COMORBIDITY; CONTINUOUS RENAL REPLACEMENT THERAPY; CORONAVIRUS DISEASE 2019; CORONAVIRUS INFECTION; CRITICALLY ILL PATIENT; DETERIORATION; HUMAN; LETTER; MULTIPLE ORGAN FAILURE; OXYGEN THERAPY; PNEUMONIA; PRIORITY JOURNAL; SHOCK; BETACORONAVIRUS; CORONAVIRINAE; VIRUS PNEUMONIA;

BETACORONAVIRUS; CORONAVIRUS; CORONAVIRUS INFECTIONS; HUMANS; PNEUMONIA; PNEUMONIA, VIRAL;

EID: 85081668552     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(20)30558-4     Document Type: Letter

References (6)

1. BBC News. Coronavirus disease named Covid-19. Feb 11, 2020. https://www.bbc.co.uk/news/world-asia-china-51466362 (accessed March 5, 2020).
2. Jiang, S, Xia, S, Ying, T, Lu, L, A novel coronavirus (2019-nCoV) causing pneumonia-associated respiratory syndrome. Cell Mol Immunol, 2020 published online Feb 5. DOI:10.1038/s41423-020-0372-4.
3. Wang, D, Hu, B, Hu, C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA, 2020 published online Feb 7. DOI:10.1001/jama.2020.1585.
4. Huang, C, Wang, Y, Li, X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395 (2020), 497–506.
5. Chen, N, Zhou, M, Dong, X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395 (2020), 507–513.
6. Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Chin J Epidemiol 4 (2020), 145–151.